Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
NCT ID: NCT02032056
Last Updated: 2018-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
40 participants
INTERVENTIONAL
2013-09-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare
NCT02180581
The Effect of Probiotics on Infections in Toddlers
NCT00823056
Probiotic for Infants
NCT07054216
The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children
NCT01935986
Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children
NCT02545634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
probiotic (10^9 cfu/day)
Daily intake of bifidobacterium animalis ssp. Lactis (BB12), 10\^9 cfu/day, provided as powder in a sachet which can be added to food or drink.
Probiotic (10^9 CFU/day)
probiotic (10^8 cfu/day)
Daily intake of bifidobacterium animalis ssp. Lactis (BB12), 10\^8 cfu/day, provided as powder in a sachet which can be added to food or drink.
Probiotic (10^8 CFU/day)
Placebo
provided as powder in a sachet which can be added to food or drink.
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic (10^9 CFU/day)
Probiotic (10^8 CFU/day)
Placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Start in daycare 4 +/- 2 weeks after intervention start
* Single born
Exclusion Criteria
* Children with a birth weight \< 2500 g
* Children suffering from severe chronic illness
* Children receiving regular medication
* Children who have received antibiotics within a month before intervention start
* Children whose parents do not speak Danish
9 Months
13 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Danish Council for Strategic Research
OTHER
Chr Hansen
INDUSTRY
Technical University of Denmark
OTHER
University of Bergen
OTHER
Odense University Hospital
OTHER
Statens Serum Institut
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arne Astrup
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Section of Paediatric and International nutrition, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen
Frederiksberg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2013-064
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
H-3-2013-064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.